Role of leukotriene receptor antagonist in improvement of symptoms after functional endoscopic sinus surgery for chronic rhinosinusitis with or without sinonasal polyposis
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20243507Keywords:
Chronic rhinosinusitis, SNOT-22, Lund-Kennedy score, Post-operativeAbstract
Background: Chronic rhinosinusitis is one of the common ENT diseases encountered daily. Due to its chronicity, it leads to patient morbidity and decreased quality-of-life of the patient. Although various medical and surgical management options are available, none can manage the condition effectively. So, the aim of the study is to evaluate the efficacy of the montelukast in the subjective and objective improvement after the FESS for patients with chronic rhino sinusitis.
Methods: This randomized controlled trial was conducted among 50 patients diagnosed with chronic rhino sinusitis. All the patients underwent FESS, and after that, they were divided into two groups; one group received the Montelukast tablet in addition to the standard post-operative regimen, and the other group received the standard post-operative medications only. The subjective and objective measurements were made using SNOT-22 and Lund-Kennedy endoscopic scores during the pre- and post-operative periods.
Results: The study showed a significant reduction in the various parameters of SNOT-22, viz runny nose (p=0.013), cough (p=0.003), post-nasal discharge (p=0.037), thick nasal discharge (p=0.013), ear fullness (p=0.021), difficulty in falling asleep (p=0.018), walking up at night (p<0.001), reduced concentration (p=0.001) in Group-A than in Group-B. The study also showed a significant reduction in the overall SNOT-22 score in the Group-A. The Lund-Kennedy endoscopic score (p=0.006) also showed a significant reduction during the postoperative period in Group-A.
Conclusion: The Montelukast positively affects the reduction of the various domains in the SNOT-22 and the Lund-Kennedy endoscopic score. It can be used as adjuvant therapy during the post-operative period in patients operated with FESS for CRS.
Metrics
References
Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016;4(4):565–72.
Mygind N, Dahl R, Bachert C. Nasal polyposis, eosinophil dominated inflammation and allergy. Thorax. 2000;55(2):79–83.
Yeolekar A, Dasgupta K, Khode S, Joshi D, Gosrani N, Prof A. A study of SNOT 22 scores in adults with no sinonasal disease. J Rhinolaryngo Oto. 2013;1;8.
Kurien R, Sunny E, Rupa V. Impact of functional endoscopic sinus surgery on patients with chronic rhinosinusitis: a prospective, cohort study among indian patients. Int J Clin Rhinol. 2019;11(1):1–6.
Tritt S, McMains KC, Kountakis SE. Unilateral nasal polyposis: clinical presentation and pathology. Am J Otolaryngol. 2008;29(4):230–2.
Alobid I, Benítez P, Bernal-Sprekelsen M, Roca J, Alonso J, Picado C, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy. 2005;60(4):452–8.
Mostafa BE, Abdel Hay H, Mohammed HE, Yamani M. Role of leukotriene inhibitors in the postoperative management of nasal polyps. ORL J Oto-Rhino-Laryngol Its Relat Spec. 2005;67(3):148–53.
Stevens WW, Schleimer RP, Chandra RK, Peters AT. Biology of nasal polyposis. J Allergy Clin Immunol. 2014;133(5):1503-6.
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(29):1–464.
Yelverton JC, Holmes TW, Johnson CM, Gelves CR, Kountakis SE. Effectiveness of leukotriene receptor antagonism in the postoperative management of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(3):243–7.
Dejaco D, Riedl D, Huber A, Moschen R, Giotakis AI, Bektic-Tadic L, et al. The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol. 2019;276(5):1355–65.
Khan AH, Reaney M, Guillemin I, Nelson L, Qin S, Kamat S, et al. Development of sinonasal outcome test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps. The Laryngoscope. 2022;132(5):933–41.
DeConde AS, Bodner TE, Mace JC, Alt JA, Rudmik L, Smith TL. Developing a clinically relevant endoscopic grading system for chronic rhinosinusitis using canonical correlation analysis. Int Forum Allergy Rhinol. 2016;6(5):478–85.
Mathiyalagen P, Davis P, Sarasveni M. Updated BG prasad socio-economic classification: The 2020 Update. Indian J Pediatr. 2021;88(1):76–7.
Santhaiah K, Kornepati LL, Devi PK. A study on evaluation of sino-nasal outcome test-22 scores in chronic rhinosinusitis patients undergoing functional endoscopic sinus surgery in a tertiary care centre. Int J Otorhinolaryngol Head Neck Surg. 2023;9(4):252–5.
Rimmer J, Fokkens W, Chong LY, Hopkins C. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database Syst Rev. 2014;(12):69-91.
Huang ZX, Li YX, Wu YB, Liu HC, Zhou B. Preoperative and postoperative medical therapies for chronic rhinosinusitis: National surveys among Chinese otolaryngologists. World J Otorhinolaryngol-Head Neck Surg. 2018;4(4):258–62.
Mahdavinia M, Grammer LC. Chronic rhinosinusitis and age: is the pathogenesis different? Expert Rev Anti Infect Ther. 2013;11(10):1029–40.
Hisinger-Mölkänen H, Piirilä P, Haahtela T, Sovijärvi A, Pallasaho P. Smoking, environmental tobacco smoke and occupational irritants increase the risk of chronic rhinitis. World Aller Organ J. 2018;11(1):6.
Hur K, Liang J, Lin SY. The role of second-hand smoke in sinusitis: a systematic review. Int Forum Allergy Rhinol. 2014;4(1):22–8.
Philpott C, Ta NH, Hopkins C, Ray J, Ahmed S, Almeyda R, et al. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes. The Laryngoscope. 2021;131(10):2179–86.
Lind H, Joergensen G, Lange B, Svendstrup F, Kjeldsen AD. Efficacy of ESS in chronic rhinosinusitis with and without nasal polyposis: a Danish cohort study. Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol-Head Neck Surg. 2016;273(4):911–9.
Abdalla S, Alreefy H, Hopkins C. Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit. Clin Otolaryngol Off J ENT-UK Off J Neth Soc Oto-Rhino-Laryngol Cervico-Facial Surg. 2012;37(4):276–82.
Schäper C, Noga O, Koch B, Ewert R, Felix SB, Gläser S, et al. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis. J Investig Allergol Clin Immunol. 2011;21(1):51–8.
Vuralkan E, Saka C, Akin I, Hucumenoglu S, Unal BU, Kuran G, et al. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps. Ther Adv Respir Dis. 2012;6(1):5–10.
